Key result
Moderate to severe chronic kidney disease independently predicted the risk of in-hospital adverse events (OR 2.24) among initially stable patients with STEMI receiving primary percutaneous coronary intervention.
Cohort (n=1,770)
Yes
Odds Ratio: 2.24 (95% CI 1.12–4.48)
Only 5.3% of initially stable STEMI patients developed in-hospital adverse events following pPCI, suggesting that routine admission to a cardiac intensive care unit may be unnecessary for the vast majority of these patients, particularly those without moderate to severe chronic kidney disease.
This comprehensive analysis by Saeed and Faeq investigates the impact of primary percutaneous coronary intervention (pPCI) on mortality among patients with ST-segment elevation myocardial infarction (STEMI) at the Erbil Cardiac Center. Analyzing data from 96 consecutive STEMI patients, the study identified significant predictors of in-hospital mortality, emphasizing the critical impact of time of hospital arrival post-symptom onset on overall prognosis. Findings indicate that factors such as atypical presentation, cardiogenic shock, chronic kidney disease, and specific coronary complications are associated with higher mortality rates. The study underscores the necessity of prompt medical intervention for improving survival outcomes in STEMI patients, especially in the high-risk subgroup. This research offers valuable insights into optimizing STEMI management and enhancing patient survival rates through effective and timely pPCI.
No takes yet. Share an insight, caveat, or question.
Bangolo et al. (2024) conducted a cohort in ST-segment elevation myocardial infarction (n=1,770). Moderate to severe chronic kidney disease vs. No or mild chronic kidney disease was evaluated on In-hospital adverse events (cardiogenic shock, in-hospital cardiac arrest, stroke, re-infarction, and death) (OR 2.24, 95% CI 1.12-4.48). Moderate to severe chronic kidney disease independently predicted the risk of in-hospital adverse events (OR 2.24) among initially stable patients with STEMI receiving primary percutaneous coronary intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: